Kate has 14 years of marketing and communications experience in both established and emerging industries such as Cannabis and CBD. As Director of Client Strategy for Brightfield Group, Kate works with a variety of organizations, including CBD/Cannabis, Pharmaceutical, and mainstream CPG clients helping both product and marketing teams make data-driven decisions. Kate received her M.B.A. from DePaul University's Kellstadt Graduate School of Business, and her B.A. in Anthropology and French from DePaul University.
Shane MacGuill conducts research and provides strategic analysis on all aspects of the global tobacco, nicotine and cannabis industries - working with a range of stakeholders to map the potential evolution and intersection of these industries. Working with a range of industry players including international manufacturers and companies in the supply chain, he contributes to discussions on industry trends and strategic development.
A frequent contributor to the mainstream and business media including CNBC, Reuters, the Economist, Bloomberg, the Financial Times, the Sunday Times and the Times of London.
There are few individuals who have been more influential in the development of the U.S. hemp industry that the U.S. Hemp Roundtable’s General Counsel, Jonathan Miller. Upon helping found the Roundtable (and its sister organization, the U.S. Hemp Authority), Jonathan has served as the industry’s leading advocate for hemp and CBD legislation on the ground in Congress and in dozens of state legislatures. A recovering politician (the Democrat was elected twice as Kentucky’s State Treasurer), Jonathan has worked across the aisle with leading hemp champions such as U.S. Senate Minority Leader Mitch McConnell on critical legislation, including the 2014 and 2018 Farm Bills. Now he spends his time working with Congress, the White House, the USDA, FDA and DEA to promote policies that advance the industry. Jonathan serves as Member in Charge of Frost Brown Todd’s Washington, D.C. office, and leads the national law firm’s broad and diverse hemp practice. Jonathan supports pro-Israel organizations and serves as President of the Robert S. Miller Family Foundation for Justice and Equity. He is a poker aficionado who made the final table in a 2012 World Series of Poker tournament.
Dr Parveen Bhatarah, PhD, FRSC, completed her PhD in organic chemistry from Imperial College London and is a Fellow of the Royal Society of Chemistry. She has over 20 years experience within the international pharmaceutical industry & regulatory environment: bulk drug substance and product development; clinical trials; commercial launches; technology transfers; and manufacturing for ANDA and MA submissions. Dr Bhatarah has 12 years’ experience in the Medicinal Cannabis industry, in which she has held various directorship roles covering everything from cultivation to FDA approval of finished medicinal products.
Eric has extensive experience advising clients in the cannabis, e-cigarette & vaping industries. He advises clients on FDA and state regulatory compliance and enforcement issues, contractual and transactional matters, and intellectual property issues. Eric was part of a landmark litigation team that helped established the legal framework for the vaping industry as it exists today by successfully arguing against FDA that e-cigarettes are not drugs or medical devices. Eric has won constitutional cases against the State of Indiana on an e-liquid manufacturer licensing scheme and against the State of New York on an emergency rule banning flavored ENDS products. Eric represents clients at all levels of the manufacturing, distribution, and retail levels of the ENDS and cannabis industries and is currently advising a large number of clients on successfully navigating the PACT Act’s requirements.
